Correction to: Stem Cell Research & Therapy (2019) 10:110
10.1186/s13287-019-1195-z
Subsequently to the publication of the above paper, the authors contacted the Editorial Office to explain that, for Angiogenesis experiments shown in Fig. 5 on p. 10, the data panel for the + PRP -ADSC + PM experiment shown in Fig. 5A was selected incorrectly. The revised (and corrected) version of Fig. 5 shown on the next page. The authors sincerely apologize for the error introduced during the preparation of this figure, although they confirm that this did not grossly affect either the results or the conclusions reported in this study. They also thank the Editor of Stem Cell Research & Therapy for granting them the opportunity to publish a Correction, and apologize to the readership for any inconvenience caused.
Fig. 5.
Angiogenesis analysis of the scaffolds over 12 weeks. a Angiogenesis assessment of the scaffolds treated with platelet-rich plasma (PRP), plasma (PM) and rat adipose-derived stem cells (rADSCs) at 12 weeks as shown by CD31 staining (n = 6). b Quantification of the number of positive CD31 cells at 6 and 12 weeks. Note that PM+ADSC and PM+ADSC+PRP scaffolds have significantly greater vessel numbers than all other scaffolds over the 12 weeks (p < 0.05). PU unmodified scaffolds, PRP platelet-rich plasma-modified scaffolds, PM argon-modified scaffold, PRP+PM platelet-rich plasma and argon modification. p values *< 0.05, **p < 0.01 and ***p < 0.001. Arrows illustrate positive CD31 stained vessels
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
M. F. Griffin, N. Naderi and D. M. Kalaskar contributed equally to this work.